UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$1.51B |
| 2 |
Accenture
ACN
|
+$1.43B |
| 3 |
Linde
LIN
|
+$1.18B |
| 4 |
Prologis
PLD
|
+$1.06B |
| 5 |
Microsoft
MSFT
|
+$908M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$818M |
| 2 |
Lam Research
LRCX
|
+$784M |
| 3 |
Blackrock
BLK
|
+$737M |
| 4 |
Meta Platforms (Facebook)
META
|
+$506M |
| 5 |
UBS Group
UBS
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.2% |
| 2 | Financials | 12.03% |
| 3 | Healthcare | 11.96% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Communication Services | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Grand Canyon Education
LOPE
$3.98B
| $14.2M | ﹤0.01% |
100,169
-7,016
| -7% | -$1.01M |
|
1077
NovoCure
NVCR
$1.91B
| $14.2M | ﹤0.01% |
907,999
+84,606
| +10% | +$1.53M |
|
|
SRCL
1078
DELISTED
Stericycle Inc
SRCL
| $14.2M | ﹤0.01% |
232,555
-318,538
| -58% | -$18.9M |
|
1079
UGI
UGI
$7.33B
| $14.2M | ﹤0.01% |
566,794
+10,105
| +2% | +$243K |
|
1080
Old National Bancorp
ONB
$10.2B
| $14.1M | ﹤0.01% |
756,814
-10,345
| -1% | -$194K |
|
1081
Recursion Pharmaceuticals
RXRX
$1.73B
| $14.1M | ﹤0.01% |
2,140,750
+43,078
| +2% | +$309K |
|
1082
Kyndryl
KD
$3.05B
| $14.1M | ﹤0.01% |
613,693
-56,277
| -8% | -$1.37M |
|
|
NUVL
1083
DELISTED
Nuvalent
NUVL
| $14.1M | ﹤0.01% |
137,821
-10,788
| -7% | -$895K |
|
1084
Cytokinetics
CYTK
$10.4B
| $14.1M | ﹤0.01% |
266,756
+14,814
| +6% | +$826K |
|
1085
DigitalOcean
DOCN
$14.6B
| $14.1M | ﹤0.01% |
348,228
-12,081
| -3% | -$431K |
|
1086
Ollie's Bargain Outlet
OLLI
$4.94B
| $14.1M | ﹤0.01% |
144,571
-13,902
| -9% | -$1.34M |
|
1087
Imperial Oil
IMO
$60.4B
| $14M | ﹤0.01% |
199,339
-40,887
| -17% | -$2.89M |
|
1088
Mueller Industries
MLI
$15.2B
| $14M | ﹤0.01% |
377,696
-34,092
| -8% | -$1.14M |
|
1089
Post Holdings
POST
$3.57B
| $14M | ﹤0.01% |
120,860
-12,389
| -9% | -$1.39M |
|
|
PR
1090
Permian Resources
PR
$16.9B
| $13.9M | ﹤0.01% |
1,024,949
+117,229
| +13% | +$1.72M |
|
1091
Carpenter Technology
CRS
$28.4B
| $13.9M | ﹤0.01% |
87,231
-9,031
| -9% | -$1.22M |
|
|
PCH
1092
DELISTED
PotlatchDeltic
PCH
| $13.9M | ﹤0.01% |
308,946
+69,887
| +29% | +$2.96M |
|
1093
Merit Medical Systems
MMSI
$5.32B
| $13.9M | ﹤0.01% |
140,816
-2,805
| -2% | -$257K |
|
1094
Crinetics Pharmaceuticals
CRNX
$8.92B
| $13.9M | ﹤0.01% |
271,747
+10,767
| +4% | +$555K |
|
1095
Cenovus Energy
CVE
$52.1B
| $13.9M | ﹤0.01% |
829,647
-72,186
| -8% | -$1.34M |
|
1096
Sensata Technologies
ST
$6.79B
| $13.8M | ﹤0.01% |
385,305
+2,471
| +0.6% | +$92K |
|
1097
Capri Holdings
CPRI
$1.74B
| $13.7M | ﹤0.01% |
321,834
+139,063
| +76% | +$4.88M |
|
1098
Flowers Foods
FLO
$1.57B
| $13.5M | ﹤0.01% |
586,008
+7,844
| +1% | +$178K |
|
1099
Cleveland-Cliffs
CLF
$6.99B
| $13.5M | ﹤0.01% |
1,056,482
-816,546
| -44% | -$11.1M |
|
1100
Range Resources
RRC
$8.95B
| $13.5M | ﹤0.01% |
437,466
-49,234
| -10% | -$1.52M |
|
Similar funds
UBS AM's Q3 2024 Portfolio in Review
As of Q3 2024, UBS AM held 2,899 positions worth $389B, up 12% from $349B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
UBS AM deployed $20.6B of net new capital in Q3 2024, opening 104 new positions and adding to 979 existing holdings. Its largest new stake was Cemex: 31,204,197 shares worth $190M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $818M trimmed.
- UBS AM's largest Q3 2024 buy was Cemex: 31,204,197 shares worth $190M.
- UBS AM added most to Pinduoduo in Q3 2024, an estimated $1.51B increase.
- UBS AM's biggest Q3 2024 reduction was Alphabet (Google) Class A, cutting an estimated $818M.
- UBS AM fully exited Vanguard Russell 1000 Growth ETF in Q3 2024, selling an estimated $128M.
- UBS AM's ten largest holdings make up 29% of its $389B portfolio in Q3 2024.
- UBS AM opened 104 new positions and closed 100 in Q3 2024.
- UBS AM's portfolio value rose 12% quarter-over-quarter to $389B.
Based on UBS AM's 13F filing for Q3 2024, filed 14 Nov 2024.